BlackRock, Inc.

Position in ANNX — Annexon, Inc.

CIK 2012383 New York, NY

Position in ANNX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$77,311,931

+$16,712,596 QoQ

Shares Held

13,539,744

+23.8% QoQ

Ownership

6.62%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 216 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. ANNX ranks #135 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$77,311,931	13,539,744	+23.8%	Shares	Sole	2026-08-07
2026-06-30	$74,962,484	13,128,281	—	Shares	Sole	2026-07-27
2026-03-31	$60,599,335	10,938,509	+22.1%	Shares	Sole	2026-05-13
2025-12-31	$44,981,372	8,960,434	+13.4%	Shares	Sole	2026-02-12
2025-09-30	$24,091,971	7,899,008	-0.8%	Shares	Sole	2025-11-12
2025-06-30	$19,109,680	7,962,368	-6.6%	Shares	Sole	2025-08-12
2025-03-31	$16,456,151	8,526,506	+0.5%	Shares	Sole	2025-05-02
2024-12-31	$43,534,136	8,486,187	+11.0%	Shares	Sole	2025-02-07
2024-09-30	$45,274,462	7,647,714	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.